(Q48356740)

10 February 2018

title

Prefrontal cortex infusions of SCH 23390 cause immediate and delayed effects on ventral tegmental area stimulation reward. (English)

1 reference

10 February 2018

author name string

C L Duvauchelle

series ordinal

1

1 reference

10 February 2018

S M Fleming

series ordinal

2

1 reference

10 February 2018

C Kornetsky

series ordinal

3

1 reference

10 February 2018

language of work or name

English

0 references

publication date

1 November 1998

1 reference

10 February 2018

published in

Brain Research

1 reference

10 February 2018

volume

811

1 reference

10 February 2018

issue

1-2

1 reference

10 February 2018

page(s)

57-62

1 reference

10 February 2018

Effects of ibotenic acid lesion of the medial prefrontal cortex on dopamine agonist-related behaviors in the rat.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

6-Hydroxydopamine lesion of the rat prefrontal cortex increases locomotor activity, impairs acquisition of delayed alternation tasks, but does not affect uninterrupted tasks in the radial maze

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

An excitant amino acid projection from the medial prefrontal cortex to the anterior part of nucleus accumbens in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

Indirect nucleus accumbens input to the prefrontal cortex via the substantia nigra pars reticulata: a combined anatomical and electrophysiological study in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

DAMGO and DPDPE facilitation of brain stimulation reward thresholds is blocked by the dopamine antagonist cis-flupenthixol.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

Involvement of delta- and mu-opioid receptors in the potentiation of brain-stimulation reward

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

Opposite effects of prefrontal cortex and nucleus accumbens infusions of flupenthixol on stimulant-induced locomotion and brain stimulation reward

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

Morphine lowering of self-stimulation thresholds: lack of tolerance with long-term administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

The combined effects of morphine and d-amphetamine on the threshold for brain stimulation reward

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

The effect of amfonelic acid or nisoxetine in combination with morphine on brain-stimulation reward

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

Differential effects of mesocortical, mesolimbic, and mesostriatal dopamine depletion on spontaneous, conditioned, and drug-induced locomotor activity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

The effects of amfonelic acid alone and in combination with naloxone on brain-stimulation reward.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

Lesions of dopamine neurons in the medial prefrontal cortex: effects on self-administration of amphetamine and dopamine synthesis in the brain of the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

Opposite influences of dopaminergic pathways to the prefrontal cortex or the septum on the dopaminergic transmission in the nucleus accumbens. An in vivo voltammetric study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

Self-stimulation of the nucleus accumbens and ventral tegmental area of tsai attenuated by microinjections of spiroperidol into the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

Opposite changes of dopamine turnover in prefrontal cortex and nucleus accumbens after amygdaloid kindling.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

Non-DA prefronto-cortical efferents modulate D1 receptors in the nucleus accumbens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

Supersensitivity to the reinforcing effects of cocaine following 6-hydroxydopamine lesions to the medial prefrontal cortex in rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

Effects of dopamine depletions in the medial prefrontal cortex on DRL performance and motor activity in the rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

Regional neuroleptic microinjections indicate a role for nucleus accumbens in lateral hypothalamic self-stimulation reward.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

Effects of 6-hydroxydopamine lesions of the medial prefrontal cortex on local cerebral blood flow and D1 and D2 dopamine receptor binding in rats: a quantitative autoradiographic study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

In vivo stimulated dopamine release in the nucleus accumbens: modulation by the prefrontal cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

Blockade of D-1 dopamine receptors in the medial prefrontal cortex produces delayed effects on pre- and postsynaptic indices of dopamine function in the nucleus accumbens.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

Opposed Behavioural Outputs of Increased Dopamine Transmission in Prefrontocortical and Subcortical Areas: A Role for the Cortical D-1 Dopamine Receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2898%2900952-4

10.1016/S0006-8993(98)00952-4

7 January 2021

Identifiers

DOI

1 reference

10 February 2018

PubMed ID

9804893

1 reference

10 February 2018